| Name | long intergenic non-protein coding RNA 462 |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n LINC00462 is a long noncoding RNA that appears to play multifaceted roles in human disease, particularly in various cancers and metabolic injuries. In non‐small cell lung cancer, reduced expression of a closely related transcript (reported as LINC00426 in one study) was associated with advanced clinical stage and worse prognosis, suggesting a potential tumor‐suppressive role in this context."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": " In contrast, in several other malignancies LINC00462 is upregulated and appears to function as an oncogene. For instance, in hepatocellular carcinoma, elevated levels of LINC00462 in tissue and exosomal RNA have been linked to enhanced tumor aggressiveness and poorer clinical outcomes, with mechanistic studies implicating its involvement in activating pathways such as PI3K/AKT"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": "and."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": " Similarly, in pancreatic cancer LINC00462 acts as a promoter of tumor progression. Experimental evidence shows that its overexpression enhances cell proliferation, migration, invasion, and epithelial–mesenchymal transition via a competing endogenous RNA mechanism involving miR‐665 and subsequent upregulation of TGFBR1 and TGFBR2, which activate the SMAD2/3 pathway."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "5"}]}, {"type": "t", "text": " In support of these findings, LINC00462 has also been identified as part of prognostic and immune‐related lncRNA signatures in pancreatic cancer"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "6"}]}, {"type": "t", "text": "and."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "7"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n Beyond cancer, LINC00462 may contribute to nonmalignant pathologies. In a high glucose–induced model of diabetic nephropathy, its knockdown alleviated oxidative stress and apoptosis in renal tubular epithelial cells via enhanced AKT activation, pointing to a pathogenic role in metabolic injury."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "8"}]}, {"type": "t", "text": " Moreover, in the context of hematological malignancies such as multiple myeloma, increased levels of LINC00462 in circulating exRNA have been proposed as potential biomarkers for relapsed and refractory disease."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "9"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n In summary, LINC00462 may function as a double‐edged sword depending on the disease context. While its downregulation correlates with poor outcome in NSCLC, its elevated expression in hepatocellular carcinoma, pancreatic cancer, and multiple myeloma is associated with enhanced tumor progression and aggressiveness. These findings underscore its potential as both a prognostic biomarker and a therapeutic target.\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Wenjun Du, Juan Sun, Jundong Gu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Bioinformatics analysis of LINC00426 expression in lung cancer and its correlation with patients' prognosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Thorac Cancer (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/1759-7714.13228"}], "href": "https://doi.org/10.1111/1759-7714.13228"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31691516"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31691516"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "JianDe Gong, XuFei Qi, Yi Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long noncoding RNA linc00462 promotes hepatocellular carcinoma progression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomed Pharmacother (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biopha.2017.06.004"}], "href": "https://doi.org/10.1016/j.biopha.2017.06.004"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28622593"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28622593"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Zhicheng Yao, Changchang Jia, Yan Tai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Serum exosomal long noncoding RNAs lnc-FAM72D-3 and lnc-EPC1-4 as diagnostic biomarkers for hepatocellular carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Aging (Albany NY) (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/aging.103355"}], "href": "https://doi.org/10.18632/aging.103355"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32554864"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32554864"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Jian-Rong Sun, Chen-Fan Kong, Kun-Min Xiao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Integrated Analysis of lncRNA-Mediated ceRNA Network Reveals a Prognostic Signature for Hepatocellular Carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Front Genet (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3389/fgene.2020.602542"}], "href": "https://doi.org/10.3389/fgene.2020.602542"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33381151"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33381151"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Bin Zhou, Weidong Guo, Chuandong Sun, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Linc00462 promotes pancreatic cancer invasiveness through the miR-665/TGFBR1-TGFBR2/SMAD2/3 pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41419-018-0724-5"}], "href": "https://doi.org/10.1038/s41419-018-0724-5"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29899418"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29899418"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Soudeh Ghafouri-Fard, Mohadeseh Fathi, Tianyue Zhai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNAs: Novel Biomarkers for Pancreatic Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomolecules (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3390/biom11111665"}], "href": "https://doi.org/10.3390/biom11111665"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34827663"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34827663"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Yalan Lei, Rong Tang, Jin Xu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Construction of a novel risk model based on the random forest algorithm to distinguish pancreatic cancers with different prognoses and immune microenvironment features."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Bioengineered (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/21655979.2021.1951527"}], "href": "https://doi.org/10.1080/21655979.2021.1951527"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34238114"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34238114"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Ruixin Wang, Yuehong Yan, Cuicui Li "}, {"type": "b", "children": [{"type": "t", "text": "LINC00462 is involved in high glucose-induced apoptosis of renal tubular epithelial cells via AKT pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Biol Int (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/cbin.11231"}], "href": "https://doi.org/10.1002/cbin.11231"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31489995"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31489995"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Maoshan Chen, Sridurga Mithraprabhu, Malarmathy Ramachandran, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Utility of Circulating Cell-Free RNA Analysis for the Characterization of Global Transcriptome Profiles of Multiple Myeloma Patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancers (Basel) (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3390/cancers11060887"}], "href": "https://doi.org/10.3390/cancers11060887"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31242667"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31242667"}]}]}]}
|
| NCBI Gene ID | 100129597 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
LINC00462 has 179 functional associations with biological entities spanning 2 categories (cell line, cell type or tissue, gene, protein or microRNA) extracted from 7 datasets.
Click the + buttons to view associations for LINC00462 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of LINC00462 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of LINC00462 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of LINC00462 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of LINC00462 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of LINC00462 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of LINC00462 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of LINC00462 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |